0 XP   0   0   0

Vaxxinity Inc
Buy, Hold or Sell?

I guess you are interested in Vaxxinity Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Vaxxinity

Let's start. I'm going to help you getting a better view of Vaxxinity Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Vaxxinity Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Vaxxinity Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Vaxxinity Inc. The closing price on 2022-09-30 was $1.98 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Vaxxinity Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Vaxxinity Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Vaxxinity earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • A Net Profit Margin of 1,189,580.5% means that $11,895.81 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vaxxinity Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1,189,580.5%-1,189,580.5%
TTM1,189,580.5%YOY-62,786.3%+1,252,366.8%
TTM1,189,580.5%5Y571,044.8%+618,535.7%
5Y571,044.8%10Y571,044.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--241.1%+241.1%
TTM1,189,580.5%-275.9%+1,189,856.4%
YOY-62,786.3%-342.1%-62,444.2%
5Y571,044.8%-475.7%+571,520.5%
10Y571,044.8%-561.7%+571,606.5%
1.1.2. Return on Assets

Shows how efficient Vaxxinity is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • -19.1% Return on Assets means that Vaxxinity generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vaxxinity Inc:

  • The MRQ is -12.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.6%TTM-19.1%+6.5%
TTM-19.1%YOY-36.1%+17.0%
TTM-19.1%5Y-23.1%+4.0%
5Y-23.1%10Y-23.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.6%-9.7%-2.9%
TTM-19.1%-8.7%-10.4%
YOY-36.1%-9.2%-26.9%
5Y-23.1%-11.5%-11.6%
10Y-23.1%-12.4%-10.7%
1.1.3. Return on Equity

Shows how efficient Vaxxinity is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • -17.7% Return on Equity means the company generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vaxxinity Inc:

  • The MRQ is -17.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.7%TTM-17.9%+0.1%
TTM-17.9%YOY--17.9%
TTM-17.9%5Y-8.9%-8.9%
5Y-8.9%10Y-8.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.7%-11.8%-5.9%
TTM-17.9%-11.0%-6.9%
YOY--10.6%+10.6%
5Y-8.9%-13.5%+4.6%
10Y-8.9%-14.5%+5.6%

1.2. Operating Efficiency of Vaxxinity Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vaxxinity is operating .

  • Measures how much profit Vaxxinity makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vaxxinity to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vaxxinity Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1,181,155.5%-1,181,155.5%
TTM1,181,155.5%YOY-39,511.8%+1,220,667.3%
TTM1,181,155.5%5Y575,595.6%+605,559.9%
5Y575,595.6%10Y575,595.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM1,181,155.5%-269.6%+1,181,425.1%
YOY-39,511.8%-309.3%-39,202.5%
5Y575,595.6%-466.7%+576,062.3%
10Y575,595.6%-572.5%+576,168.1%
1.2.2. Operating Ratio

Measures how efficient Vaxxinity is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11,811.625+11,811.625
TTM-11,811.625YOY397.529-12,209.154
TTM-11,811.6255Y-5,754.961-6,056.664
5Y-5,754.96110Y-5,754.9610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-11,811.6253.542-11,815.167
YOY397.5293.491+394.038
5Y-5,754.9615.744-5,760.705
10Y-5,754.9617.007-5,761.968

1.3. Liquidity of Vaxxinity Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vaxxinity is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 416.6% means the company has $4.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vaxxinity Inc:

  • The MRQ is 4.166. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.657. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.166TTM4.657-0.491
TTM4.657YOY4.012+0.644
TTM4.6575Y3.833+0.824
5Y3.83310Y3.8330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1665.266-1.100
TTM4.6576.060-1.403
YOY4.0126.365-2.353
5Y3.8336.692-2.859
10Y3.8336.457-2.624
1.3.2. Quick Ratio

Measures if Vaxxinity is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 373.7% means the company can pay off $3.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vaxxinity Inc:

  • The MRQ is 3.737. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.269. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.737TTM4.269-0.531
TTM4.269YOY1.698+2.570
TTM4.2695Y2.771+1.497
5Y2.77110Y2.7710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7373.985-0.248
TTM4.2694.865-0.596
YOY1.6985.192-3.494
5Y2.7715.275-2.504
10Y2.7714.997-2.226

1.4. Solvency of Vaxxinity Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vaxxinity assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.29 means that Vaxxinity assets are financed with 28.9% credit (debt) and the remaining percentage (100% - 28.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.289. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.265. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.265+0.024
TTM0.265YOY2.495-2.230
TTM0.2655Y1.068-0.803
5Y1.06810Y1.0680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.271+0.018
TTM0.2650.269-0.004
YOY2.4950.296+2.199
5Y1.0680.361+0.707
10Y1.0680.399+0.669
1.4.2. Debt to Equity Ratio

Measures if Vaxxinity is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 40.7% means that company has $0.41 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.407. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.253. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.407TTM0.253+0.154
TTM0.253YOY-+0.253
TTM0.2535Y0.127+0.127
5Y0.12710Y0.1270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4070.310+0.097
TTM0.2530.311-0.058
YOY-0.310-0.310
5Y0.1270.382-0.255
10Y0.1270.438-0.311

2. Market Valuation of Vaxxinity Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Vaxxinity.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -1.72 means the investor is paying $-1.72 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vaxxinity Inc:

  • The EOD is -2.166. Company is losing money. -2
  • The MRQ is -1.717. Company is losing money. -2
  • The TTM is -2.658. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.166MRQ-1.717-0.448
MRQ-1.717TTM-2.658+0.940
TTM-2.658YOY--2.658
TTM-2.6585Y-1.329-1.329
5Y-1.32910Y-1.3290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.166-2.150-0.016
MRQ-1.717-2.332+0.615
TTM-2.658-3.889+1.231
YOY--5.087+5.087
5Y-1.329-3.697+2.368
10Y-1.329-3.390+2.061
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Vaxxinity.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Vaxxinity Inc:

  • The MRQ is 0.093. Very good. +2
  • The TTM is 0.093. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.093TTM0.0930.000
TTM0.0935Y0.0930.000
5Y0.09310Y0.0930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0930.004+0.089
TTM0.0930.019+0.074
5Y0.0930.021+0.072
10Y0.0930.017+0.076

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Vaxxinity is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.99 means the investor is paying $1.99 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vaxxinity Inc:

  • The EOD is 2.507. Good. +1
  • The MRQ is 1.988. Good. +1
  • The TTM is 3.026. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.507MRQ1.988+0.519
MRQ1.988TTM3.026-1.038
TTM3.026YOY-+3.026
TTM3.0265Y1.513+1.513
5Y1.51310Y1.5130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.5071.816+0.691
MRQ1.9881.961+0.027
TTM3.0262.789+0.237
YOY-3.538-3.538
5Y1.5132.782-1.269
10Y1.5132.419-0.906

2.4. Latest News of Vaxxinity Inc

Does Vaxxinity Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Vaxxinity Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-13
14:00
Vaxxinity Announces First Subjects Dosed in Phase 1 Clinical Trial of UB-313 for Preventive Treatment of MigraineRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vaxxinity Inc.

3.1. Institutions holding Vaxxinity Inc

Institutions are holding 23.3% of the shares of Vaxxinity Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Prime Movers Lab LLC14.162613.431217848314-179000-0.9929
2022-06-30Bank of America Corp2.55180.00063215891320003320179.2975
2022-06-30Vanguard Group Inc1.21450.0001153052014753992676.655
2022-03-31Adage Capital Partners Gp LLC0.79480.0082100167000
2022-06-30Marshall Wace Asset Management Ltd0.49230.0026204596204590
2022-06-30Element Capital Management LLC0.29910.2973768863768860
2022-06-30SCOGGIN LLC0.22310.209328116900
2022-06-30Creative Planning Inc0.22020.00072775212775210
2022-06-30Millennium Management LLC0.16950.00022136202136200
2022-06-30Two Sigma Investments LLC0.1020.00071285161285160
2022-06-30Ghisallo Capital Management LLC0.07940.01941000001000000
2022-03-31Goldman Sachs Group Inc0.0770.000197069-124031-56.0972
2022-06-30Geode Capital Management, LLC0.05406809600
2022-03-31ETF Managers Group, LLC0.030.003437841-43-0.1135
2022-06-30BB&T Corp.0.01650.000120738207380
2022-06-30Hollencrest Securities, LLC0.01590.003620000200000
2022-03-31HRT FINANCIAL LLC0.01360.000517090-33924-66.4994
2022-06-30Squarepoint Ops LLC0.01220.000115417154170
2022-06-30Dynamic Technology Lab Private Ltd0.01080.002413582135820
2022-06-30Virtu Financial LLC0.01010.001712760127600
Total 20.549413.981325897159  

3.2. Funds holding Vaxxinity Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv1.18170.0002148927400
2022-07-31Fidelity® NASDAQ Composite Index®0.0540.00116809600
2022-07-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03190.00034023100
2022-08-31ETFMG Treatments Testing and Adv ETF0.03050.35443843200
2022-06-30USAA Extended Market Index0.00380.00114758-24-0.5019
2022-06-30JHVIT Total Stock Market Index I0.00170.0005215000
2022-07-31Vanguard Balanced Index Inv0.00080101500
2022-02-28The Vanguard Total Stock Market Index0.0002022300
Total 1.30460.35761644179  

3.3. Insider Transactions

Insiders are holding 55.925% of the shares of Vaxxinity Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-06Movers Lab Fund I Lp PrimeSELL252432.49451674
2022-08-25Movers Lab Fund I Lp PrimeSELL227572.339476917
2022-08-23Movers Lab Fund I Lp PrimeSELL337852.459583460
2022-06-16Lou ReeseBUY1000001.9951737344
2022-06-13Movers Lab Fund I Lp PrimeSELL925692.439617245
2022-06-10Movers Lab Fund I Lp PrimeSELL283782.89709814
2022-06-09Mei Mei HuBUY109782.7251637344
2022-06-08United Biomedical IncBUY100002.9551626366
2022-04-27Lou ReeseBUY48073.5851616366
2022-04-26United Biomedical IncBUY181053.4551611559
2022-04-25Mei Mei HuBUY80383.3751593454

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vaxxinity Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.7900.870-9%-0.967+222%0.072+993%0.072+993%
Book Value Per Share Growth---0.1350.482-128%-0.379+180%0.099-237%0.099-237%
Current Ratio--4.1664.657-11%4.012+4%3.833+9%3.833+9%
Debt To Asset Ratio--0.2890.265+9%2.495-88%1.068-73%1.068-73%
Debt To Equity Ratio--0.4070.253+61%-+100%0.127+222%0.127+222%
Dividend Per Share----0%-0%-0%-0%
Eps---0.140-0.229+63%-0.355+154%-0.255+82%-0.255+82%
Eps Growth---18.514-18.5140%---18.5140%-18.5140%
Gains Per Share---0.1350.482-128%-0.379+180%0.099-237%0.099-237%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---11895.805-100%-627.8630%5710.448-100%5710.448-100%
Operating Margin---11811.555-100%-395.1180%5755.956-100%5755.956-100%
Operating Ratio----11811.6250%397.529-100%-5754.9610%-5754.9610%
Pb Ratio2.507+21%1.9883.026-34%-+100%1.513+31%1.513+31%
Pe Ratio-2.166-26%-1.717-2.658+55%--100%-1.329-23%-1.329-23%
Peg Ratio--0.0930.0930%--0.0930%0.0930%
Price Per Share1.980+21%1.5702.870-45%-+100%1.435+9%1.435+9%
Quick Ratio--3.7374.269-12%1.698+120%2.771+35%2.771+35%
Return On Assets---0.126-0.191+52%-0.361+186%-0.231+83%-0.231+83%
Return On Equity---0.177-0.179+1%--100%-0.089-50%-0.089-50%
 EOD+1 -2MRQTTM+5 -10YOY+10 -45Y+7 -810Y+7 -8

4.2. Fundamental Score

Let's check the fundamental score of Vaxxinity Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.166
Price to Book Ratio (EOD)Between0-12.507
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.737
Current Ratio (MRQ)Greater than14.166
Debt to Asset Ratio (MRQ)Less than10.289
Debt to Equity Ratio (MRQ)Less than10.407
Return on Equity (MRQ)Greater than0.15-0.177
Return on Assets (MRQ)Greater than0.05-0.126
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vaxxinity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.739
Ma 20Greater thanMa 502.144
Ma 50Greater thanMa 1002.170
Ma 100Greater thanMa 2002.524
OpenGreater thanClose2.030
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets136,996
Total Liabilities39,655
Total Stockholder Equity97,341
 As reported
Total Liabilities 39,655
Total Stockholder Equity+ 97,341
Total Assets = 136,996

Assets

Total Assets136,996
Total Current Assets122,022
Long-term Assets122,022
Total Current Assets
Cash And Cash Equivalents 109,066
Net Receivables 400
Other Current Assets 12,556
Total Current Assets  (as reported)122,022
Total Current Assets  (calculated)122,022
+/-0
Long-term Assets
Property Plant Equipment 12,898
Long-term Assets Other 2,076
Long-term Assets  (as reported)14,974
Long-term Assets  (calculated)14,974
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,290
Long-term Liabilities10,365
Total Stockholder Equity97,341
Total Current Liabilities
Short-term Debt 384
Short Long Term Debt 384
Accounts payable 28,906
Total Current Liabilities  (as reported)29,290
Total Current Liabilities  (calculated)29,674
+/- 384
Long-term Liabilities
Long term Debt Total 10,129
Long-term Liabilities Other 236
Long-term Liabilities  (as reported)10,365
Long-term Liabilities  (calculated)10,365
+/-0
Total Stockholder Equity
Common Stock278
Retained Earnings Total Equity-264,996
Capital Surplus 362,059
Total Stockholder Equity (as reported)97,341
Total Stockholder Equity (calculated)97,341
+/-0
Other
Capital Stock278
Cash and Short Term Investments 109,066
Common Stock Shares Outstanding 123,229
Common Stock Total Equity278
Liabilities and Stockholders Equity 136,996
Net Invested Capital 107,854
Net Tangible Assets 97,341
Net Working Capital 92,732



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-06-302020-03-31
> Total Assets 
0
0
50,141
0
141,889
134,916
166,673
147,528
136,996
136,996147,528166,673134,916141,889050,14100
   > Total Current Assets 
0
0
35,674
66,403
127,452
104,054
154,129
133,348
122,022
122,022133,348154,129104,054127,45266,40335,67400
       Cash And Cash Equivalents 
0
0
31,143
0
110,845
89,375
144,885
124,766
109,066
109,066124,766144,88589,375110,845031,14300
       Net Receivables 
0
0
26
366
372
380
393
399
400
4003993933803723662600
       Other Current Assets 
0
0
832
0
16,235
14,299
8,851
8,183
12,556
12,5568,1838,85114,29916,235083200
   > Long-term Assets 
0
0
14,467
0
14,437
6,189
12,345
14,180
14,974
14,97414,18012,3456,18914,437014,46700
       Property Plant Equipment 
0
0
0
11,875
11,593
11,382
12,173
12,594
12,898
12,89812,59412,17311,38211,59311,875000
       Intangible Assets 
0
0
0
0
0
13,217
0
0
0
00013,21700000
       Other Assets 
0
0
0
3,214
2,844
6,263
371
1,586
0
01,5863716,2632,8443,214000
> Total Liabilities 
0
0
137,516
0
283,707
41,286
38,054
34,873
39,655
39,65534,87338,05441,286283,7070137,51600
   > Total Current Liabilities 
0
0
37,224
12,591
21,958
30,680
27,494
24,411
29,290
29,29024,41127,49430,68021,95812,59137,22400
       Short-term Debt 
0
0
0
0
787
425
376
380
384
3843803764257870000
       Short Long Term Debt 
0
0
27,593
0
787
425
376
380
384
384380376425787027,59300
       Accounts payable 
0
0
1,017
1,930
5,882
30,255
27,118
24,031
28,906
28,90624,03127,11830,2555,8821,9301,01700
       Other Current Liabilities 
0
0
0
2,932
15,289
21,216
19,407
16,787
0
016,78719,40721,21615,2892,932000
   > Long-term Liabilities 
0
0
100,292
0
261,749
10,606
10,560
10,462
10,365
10,36510,46210,56010,606261,7490100,29200
       Long term Debt Total 
0
0
0
0
0
10,366
10,323
10,226
10,129
10,12910,22610,32310,36600000
       Warrants
0
0
0
0
0
501,994
0
0
0
000501,99400000
       Other Liabilities 
0
0
0
2,380
240
240
237
236
0
02362372402402,380000
       Deferred Long Term Liability 
0
0
0
3,116
2,786
6,189
0
0
0
0006,1892,7863,116000
> Total Stockholder Equity
0
0
-87,375
0
-141,818
-157,367
128,619
112,655
97,341
97,341112,655128,619-157,367-141,8180-87,37500
   Common Stock
0
0
0
249
255
255
278
278
278
278278278255255249000
   Retained Earnings Total Equity-264,996-247,744-229,481-181,29000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
0
0
0
0
0
23,668
357,822
360,121
362,059
362,059360,121357,82223,66800000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
8,825
0
0
0
0
00008,8250000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue66
Cost of Revenue-1,937
Gross Profit-1,871-1,871
 
Operating Income (+$)
Gross Profit-1,871
Operating Expense-123,204
Operating Income-125,075-125,075
 
Operating Expense (+$)
Research Development71,379
Selling General Administrative51,825
Selling And Marketing Expenses-
Operating Expense123,204123,204
 
Net Interest Income (+$)
Interest Income9
Interest Expense-840
Net Interest Income-831-831
 
Pretax Income (+$)
Operating Income-125,075
Net Interest Income-831
Other Non-Operating Income Expenses-12,100
Income Before Tax (EBT)-137,175-112,975
EBIT - interestExpense = -137,175
-137,175
-136,335
Interest Expense840
Earnings Before Interest and Taxes (ebit)-136,335-136,335
Earnings Before Interest and Taxes (ebitda)-135,233
 
After tax Income (+$)
Income Before Tax-137,175
Tax Provision-0
Net Income From Continuing Ops-137,175-137,175
Net Income-137,175
Net Income Applicable To Common Shares-137,175
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses125,141
Total Other Income/Expenses Net-12,10012,931
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
DFI.CC
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of DFI.CC.

DFI.CC Daily Candlestick Chart
DERI.CC
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DERI.CC.

DERI.CC Daily Candlestick Chart
DDX.CC
2 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DDX.CC.

DDX.CC Daily Candlestick Chart
DAO.CC
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of DAO.CC.

DAO.CC Daily Candlestick Chart
COMB.CC
7 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of COMB.CC.

COMB.CC Daily Candlestick Chart
CAP.CC
12 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of CAP.CC.

CAP.CC Daily Candlestick Chart
BTSC.CC
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BTSC.CC.

BTSC.CC Daily Candlestick Chart
BTCZ.CC
14 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of BTCZ.CC.

BTCZ.CC Daily Candlestick Chart
BTCR.CC
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BTCR.CC.

BTCR.CC Daily Candlestick Chart
BT.CC
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BT.CC.

BT.CC Daily Candlestick Chart
BITCOIVA.CC
18 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of BITCOIVA.CC.

BITCOIVA.CC Daily Candlestick Chart
BCX.CC
18 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BCX.CC.

BCX.CC Daily Candlestick Chart
ATOMBULL.CC
22 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ATOMBULL.CC.

ATOMBULL.CC Daily Candlestick Chart
ATMOS.CC
22 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of ATMOS.CC.

ATMOS.CC Daily Candlestick Chart
ASY.CC
23 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ASY.CC.

ASY.CC Daily Candlestick Chart
ASP.CC
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASP.CC.

ASP.CC Daily Candlestick Chart
ARGUS.CC
24 minutes ago

I found you a Golden Cross on the daily chart of ARGUS.CC.

ARGUS.CC Daily Candlestick Chart
AMPL.CC
24 minutes ago

I found you a Death Cross on the daily chart of AMPL.CC.

AMPL.CC Daily Candlestick Chart
AIB.CC
26 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AIB.CC.

AIB.CC Daily Candlestick Chart
AENS.CC
26 minutes ago

I found you a Bearish Engulfing Candle Pattern on the daily chart of AENS.CC.

AENS.CC Daily Candlestick Chart
ACA1.CC
28 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of ACA1.CC.

ACA1.CC Daily Candlestick Chart
AAB.CC
28 minutes ago

I found you a Death Cross on the daily chart of AAB.CC.

AAB.CC Daily Candlestick Chart
ZPAE.CC
30 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ZPAE.CC.

ZPAE.CC Daily Candlestick Chart
ZIPT.CC
30 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of ZIPT.CC.

ZIPT.CC Daily Candlestick Chart
XNODE.CC
34 minutes ago

I found you a Death Cross on the daily chart of XNODE.CC.

XNODE.CC Daily Candlestick Chart